Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
395
-
Total 13F shares, excl. options
-
46.1M
-
Shares change
-
+1.09M
-
Total reported value, excl. options
-
$6.55B
-
Value change
-
+$153M
-
Put/Call ratio
-
1.22
-
Number of buys
-
179
-
Number of sells
-
-188
-
Price
-
$141.90
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q2 2019
453 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q2 2019.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 395 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.1M shares
of 50.5M outstanding shares and own 91.37% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.19M shares), BlackRock Inc. (4.66M shares), AQR CAPITAL MANAGEMENT LLC (2.24M shares), RENAISSANCE TECHNOLOGIES LLC (1.66M shares), FMR LLC (1.59M shares), STATE STREET CORP (1.19M shares), WELLS FARGO & COMPANY/MN (1.04M shares), Bank of New York Mellon Corp (978K shares), FIRST TRUST ADVISORS LP (927K shares), and TimesSquare Capital Management, LLC (908K shares).
This table shows the top 395 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.